NKE Forensic Analysis

PART 1: TRADING EXECUTION

1. Trading Setup & Entry Strategy

Thesis: NKE is a classic "Bad News is Priced In" play. Despite horrific earnings (Net Income -32%) and a China collapse (-17%), the stock has rallied +10% in 5 days. The catalyst: Breaking news of a CEO stock purchase coupled with a massive pivot in North American Wholesale (+24%). We are trading the capitulation bottom, not the fundamental growth story.

• •Strategy: MEAN REVERSION / MOMENTUM BREAKOUT
• •Timeframe: Swing (2-4 Weeks)
• •Conviction: Medium-High (Tactical), Low (Structural)

Actionable Orders:

1. •Entry Zone A (Momentum): Buy a starter position (40%) on a confirmed daily close above the 50-Day SMA ($64.04). This confirms the trend shift.
2. •Entry Zone B (Pullback): Buy the dip (40%) at $61.20 - $61.50 (retest of the 5/10 Day SMA crossover).
3. •Add Zone: Add remaining 20% only if price reclaims $67.00 (200-Day SMA proximity).

Risk Management:

• •Stop Loss (HARD): $59.40. This places the stop below the recent 10-day moving average and the psychological $60 level. If it breaks $59.40, the CEO buy signal has failed, and the downtrend resumes.
• •Take Profit:
  • •TP1: $66.70 (200-Day SMA resistance) - Trim 50%.
  • •TP2: $70.20 (Upper Bollinger Band) - Trim 30%.
  • •TP3: Runner for gap fill to $75.00.
• •Risk/Reward: 1:3.2 at optimal entry.

---

PART 2: DETAILED RESEARCH

2. Executive Summary

Analysis Date: 2025-12-31 | Price: $63.54

NKE is currently a battleground between deteriorating macro fundamentals and bullish technical divergence. Q2 2026 earnings showed a massive margin contraction (40.6%, down 300bps) and a collapse in China. However, the market is aggressively buying this bad news, likely fueled by the North America Wholesale pivot (+24% YoY) and a CEO Insider Buy disclosed today. The "Widowmaker" rule applies here: Do not short this momentum despite the high valuation (PE ~30x on depressed earnings).

3. Recent Material Events (8-K Analysis)

• •Dec 18, 2025: 8-K filing confirms no major corporate governance changes, implying stability post-earnings.
• •Nov 2025: Moody's Downgrade (A1 to A2). Debt costs are rising, but interest coverage remains adequate. This news is stale and likely priced in at the $50s lows.

4. Insider Trading Activity & Institutional Flow

• •MAJOR SIGNAL: CEO Stock Purchase (Dec 30/31 News). Breaking news indicates the CEO has stepped in to buy shares. In a large-cap decline, C-suite buying is the strongest possible reversal signal.
• •Context: Previous filings (Oct/Nov 2025) showed executives (CFO Friend, innovation chief McCartney) adopting 10b5-1 plans to sell. The shift to a CEO buy creates a powerful divergence from previous insider sentiment.

5. Current News & Market Context

• •CEO Buy Catalyst: Premarket action today (+3.84%) is directly attributed to the CEO's disclosure. This forces short covering.
• •Macro: Jobless claims were better than expected, aiding consumer discretionary stocks.
• •Tariffs: New tariffs in North America are citing a $1.5B annualized cost impact. This is the primary driver of the gross margin crush.

6. Business Model Analysis

• •Channel Shift: The "Direct-to-Consumer" (DTC) strategy is failing (Direct -10%). Management is aggressively pivoting back to Wholesale (North America Wholesale +24%). This creates short-term margin pain but long-term volume stability.
• •Pricing Power: Eroding. ASP (Average Selling Price) is down due to higher discounts to clear inventory. NKE is no longer commanding premium pricing power in this cycle.

7. Financial Health (Q2 2026 10-Q)

8. Valuation Analysis

• •Current P/E: ~30x (Annualized EPS ~$2.12 based on Q2).
• •Reverse DCF: At $63.54, the market implies NKE will return to 12-14% growth immediately.
• •Verdict: Fundamentals say SHORT (Overvalued). However, we must respect the Technical "Widowmaker" rule. The market is pricing in a trough in earnings, looking past the current P/E compression.

9. Management Quality

• •Pivot Execution: Management's pivot back to Wholesale is showing up in the numbers (+24% NA Wholesale). They are admitting the DTC mistake.
• •Credibility: Low, due to repeated guidance cuts, but the Insider Buy suggests they believe the bottom is in.

10. Forensic Accounting Flags

• •Revenue Quality: ⚠️ Accounts Receivable increased, likely due to the shift back to Wholesale. This increases working capital drag compared to DTC cash-up-front.
• •Inventory/COGS: Inventory (+3%) is growing faster than Revenue (+1%). This implies future markdowns are still needed. Gross Margin pressure will persist.

11. Technical Analysis & Trade Timing

• •Trend: Daily trend is changing from Bearish to Neutral/Bullish.
• •Momentum: Price is +10.8% in 5 days.
• •Moving Averages: Price ($63.54) is challenging the 50-Day SMA ($64.04). A close above this is the "Go" signal.
• •RSI: 48.17. Neutral. Plenty of room to run before hitting Overbought (70).
• •Bollinger Bands: Bounced hard off the lower band ($56.80). Target is the upper band ($70.24).

12. Investment Recommendation

RATING: TACTICAL BUY (High Risk)

While the fundamentals are atrocious (margin collapse, China weakness), the price action indicates capitulation. The combination of a CEO buy, a successful pivot to wholesale in North America, and a +10% momentum thrust off the lows suggests the "bad news is priced in."

Warning: Do not marry this trade. It is a technical bounce play. If NKE fails to hold $60, the thesis is void.

One-Liner Thesis: NKE is a "trash rally" opportunity where horrific earnings are being bought due to CEO insider buying and a tangible pivot back to wholesale distribution.